Literature DB >> 21280072

Pain and death: neurodegenerative disease mechanisms in the nociceptor.

David B Reichling1, Jon D Levine.   

Abstract

Chronic peripheral neuropathic pain is the result of abnormal activity in sensory nerves. It is well recognized that this sensory nerve dysfunction can be caused by traumatic, toxic, or metabolic insult to the nerve. In addition, there is growing recognition that neuropathic pain is a frequent manifestation of neurodegenerative diseases. In this regard, important clues to the cellular mechanisms of neuropathic pain may be found by close examination of neurodegenerative diseases (including Parkinson's disease) in which neuropathic pain is often an underappreciated but important clinical manifestation. This approach identifies specific mitochondrial and cytoskeletal mechanisms, previously implicated in the pathophysiology of neurodegenerative diseases in the central nervous system, that might contribute to neuropathic dysfunction in peripheral sensory nerve fibers. Investigations in preclinical models of common peripheral neuropathic pain conditions have supported the idea that a subset of these cellular mechanisms of neurodegeneration can produce painful hyperactivity in primary afferent nociceptors. Importantly, this emerging concept of neurodegenerative disease mechanisms in the primary afferent nociceptor identifies novel molecular targets for the treatment neuropathic pain.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280072     DOI: 10.1002/ana.22351

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Association Between Burning Mouth Syndrome and the Development of Depression, Anxiety, Dementia, and Parkinson Disease.

Authors:  Jong-Yeup Kim; Yeon Soo Kim; Inseok Ko; Dong-Kyu Kim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

Review 2.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 3.  Apoptosis and (in) Pain-Potential Clinical Implications.

Authors:  Hugo Ribeiro; Ana Bela Sarmento-Ribeiro; José Paulo Andrade; Marília Dourado
Journal:  Biomedicines       Date:  2022-05-27

Review 4.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

5.  Current and emerging "at-site" pain medications: a review.

Authors:  Praveen Pn Rao; Tarek Mohamed
Journal:  J Pain Res       Date:  2011-09-08       Impact factor: 3.133

6.  Prolactin receptor expression in mouse dorsal root ganglia neuronal subtypes is sex-dependent.

Authors:  Mayur Patil; Anahit H Hovhannisyan; Andi Wangzhou; Jennifer Mecklenburg; Wouter Koek; Vincent Goffin; David Grattan; Ulrich Boehm; Gregory Dussor; Theodore J Price; Armen N Akopian
Journal:  J Neuroendocrinol       Date:  2019-07-04       Impact factor: 3.870

7.  Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.

Authors:  Jessica Grigoletto; Katharina Pukaß; Ayelet Gamliel; Dana Davidi; Rachel Katz-Brull; Christiane Richter-Landsberg; Ronit Sharon
Journal:  Acta Neuropathol Commun       Date:  2017-05-08       Impact factor: 7.801

Review 8.  Tapentadol for neuropathic pain: a review of clinical studies.

Authors:  Ulderico Freo; Patrizia Romualdi; Hans G Kress
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

Review 9.  Re-thinking the Etiological Framework of Neurodegeneration.

Authors:  Ximena Castillo; Susana Castro-Obregón; Benjamin Gutiérrez-Becker; Gabriel Gutiérrez-Ospina; Nikolaos Karalis; Ahmed A Khalil; José Sócrates Lopez-Noguerola; Liliana Lozano Rodríguez; Eduardo Martínez-Martínez; Claudia Perez-Cruz; Judith Pérez-Velázquez; Ana Luisa Piña; Karla Rubio; Héctor Pedro Salazar García; Tauqeerunnisa Syeda; America Vanoye-Carlo; Arno Villringer; Katarzyna Winek; Marietta Zille
Journal:  Front Neurosci       Date:  2019-07-24       Impact factor: 4.677

10.  Melatonin in antinociception: its therapeutic applications.

Authors:  Venkatramanujam Srinivasan; Edward C Lauterbach; Khek Yu Ho; Dario Acuña-Castroviejo; Rahimah Zakaria; Amnon Brzezinski
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.